Insights

  • Date

  • Content Type

  • Reset

Blog

Roadmap to commercialization success: Build agility into drug development plans

29.11.21

By Dr. Diane Seimetz

We know the lifechanging impact that gene, cell and tissue-based therapies..

Blog

The new economics of innovative therapies: Navigating emerging payment models

11.11.21

By Alberto Rubio

For years, market access strategies for new therapies almost exclusively depended on data supporting efficacy...

Blog

Accelerating commercialization of advanced therapies: it’s time to map a new route to market

26.10.21

by Christian K. Schneider, MD

For decades, advanced therapies have shown potential to disrupt the $1 trillion global...

Blog

Biopharma’s Big Inflection Point: There’s never been a better time to innovate with next-generation medicine

11.10.21

by Christian K. Schneider, MD

In all of the years I have been tracking and helping to drive...

White Paper

The Future of Advanced Therapies: Strategies to Evolve Global Health in a Post-COVID World

01.10.21
Driven by scientific innovations and impressive clinical outcomes, next-generation therapies are on the threshold of

Blog

How to create a smart integrated drug development plan including considerations for cell and gene therapies

29.06.21

by Diane Seimetz

An integrated drug development plan is a critical tool for the efficient and effective progression...